1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Ortho Biotech

Anonymous board for Ortho Biotech


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    12
    Views:
    3,939
  2. Anonymous
    Replies:
    0
    Views:
    3,771
  3. Anonymous
    Replies:
    3
    Views:
    8,585
  4. Anonymous
    Replies:
    2
    Views:
    3,806

Thread Display Options

Loading...